News

Published on 15 Nov 2023 on Simply Wall St. via Yahoo Finance

Athira Pharma Insiders Placed Bullish Bets Worth US$556.3k


Article preview image

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of Athira Pharma, Inc. (NASDAQ:ATHA), it sends a favourable message to the company's shareholders.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

View our latest analysis for Athira Pharma

NASDAQ.ATHA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
One Athira Pharma Insider Raised Their Stake In The Previous Year

Viewing insider transactions for Athira Pharma, Inc.'s (NASDAQ:ATHA ) over the last year, we see ...

Simply Wall St. via Yahoo Finance 24 Apr 2024

Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 29 Mar 2024

Athira Pharma, Inc. (ATHA) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 28 Feb 2024

Athira Pharma Insiders Placed Bullish Bets Worth US$556.3k

Generally, when a single insider buys stock, it is usually not a big deal. However, when several ...

Simply Wall St. via Yahoo Finance 15 Nov 2023

Athira Pharma, Inc. (ATHA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

The price trend for Athira Pharma, Inc. (ATHA) has been bearish lately and the stock has lost 10....

Zacks via Yahoo Finance 29 Aug 2023

FDA Rejects ImmunityBio's (IBRX) Bladder Cancer Therapy Filing

Shares of ImmunityBio IBRX were down 55.1% on Thursday after management announced that FDA issued...

Zacks via Yahoo Finance 12 May 2023

Novavax (NVAX) Q1 Earnings Lag, Stock Up 28% on Upbeat '23 View

Novavax, Inc. NVAX incurred a loss of $3.41 per share for first-quarter 2023, which was wider tha...

Zacks via Yahoo Finance 10 May 2023

Athira Pharma, Inc. (NASDAQ:ATHA) is a favorite amongst institutional investors who own 58%

Key Insights Given the large stake in the stock by institutions, Athira Pharma's stock price migh...

Simply Wall St. via Yahoo Finance 29 Apr 2023

Athira Pharma, Inc. (ATHA) Upgraded to Buy: What Does It Mean for the Stock?

Athira Pharma, Inc. (ATHA) could be a solid addition to your portfolio given its recent upgrade t...

Zacks via Yahoo Finance 28 Mar 2023

Former Athira CEO on her controversial exit: 'I was relieved that it came to an end'

Leen Kawas resigned as Athira's CEO in October 2021 after an investigation into her doctoral work...

American City Business Journals 21 Jan 2023